Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase

There are provided novel compounds of formula (I), wherein R.sub.1, R.sub.2, R.sub.3, T, U, X, Y, V and W are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain. 1